{"transactions":[{"id":4638787,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":28789,"kind":"person","name":"Stout Jay S","position":1,"cik":"0001702969","reported_name":"Stout Jay S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-10-09T21:05:59.000Z","date":"2026-10-07","kind":"sale","planned":false,"acquired":false,"shares":1596,"price":32.06,"value":51167.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On April 2, 2024, the holder was granted 54,978 RSUs, as previously reported on a Form 4 filed on April 4, 2024, of which 3,437 of these RSUs vested on October 2, 2026. The sale reported on this\nForm 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.58 - $32.30 per share, inclusive. The Reporting Person undertakes to provide\nto the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nrange set forth in this footnote to this Form 4."}],"balance_after":201532,"source":{"system":"sec-edgar","filing":"0001702969-26-000012","document":"wk-form4_1791579957.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000170296926000012/wk-form4_1791579957.xml","form_type":"4"}},{"id":4638786,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":28789,"kind":"person","name":"Stout Jay S","position":1,"cik":"0001702969","reported_name":"Stout Jay S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-10-09T21:05:59.000Z","date":"2026-10-07","kind":"sale","planned":false,"acquired":false,"shares":2213,"price":32.06,"value":70948.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 1, 2025, the holder was granted 76,181 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on April 3, 2025, of which 4,761 of these RSUs vested on October 1, 2026.\nThe sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.58 - $32.30 per share, inclusive. The Reporting Person undertakes to provide\nto the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nrange set forth in this footnote to this Form 4."}],"balance_after":203128,"source":{"system":"sec-edgar","filing":"0001702969-26-000012","document":"wk-form4_1791579957.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000170296926000012/wk-form4_1791579957.xml","form_type":"4"}},{"id":703529,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":28789,"kind":"person","name":"Stout Jay S","position":1,"cik":"0001702969","reported_name":"Stout Jay S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-07-24T21:57:15.000Z","date":"2026-07-23","kind":"sale","planned":false,"acquired":false,"shares":2857,"price":38.69,"value":110537.33,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 17, 2023, the holder was granted 100,000 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on April 19, 2023, of which 6,250 of these RSUs vested on July 17,\n2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is\nmandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.18 - $39.05 per share, inclusive. The Reporting Person undertakes to provide\nto the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nrange set forth in this footnote to this Form 4."}],"balance_after":205341,"source":{"system":"sec-edgar","filing":"0001702969-26-000010","document":"wk-form4_1784930232.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000170296926000010/wk-form4_1784930232.xml","form_type":"4"}},{"id":711209,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":28789,"kind":"person","name":"Stout Jay S","position":1,"cik":"0001702969","reported_name":"Stout Jay S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-07-10T20:12:58.000Z","date":"2026-07-08","kind":"sale","planned":false,"acquired":false,"shares":77,"price":39.99,"value":3079.23,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"On April 2, 2024, the holder was granted 54,978 RSUs, as previously reported on a Form 4 filed on April 4, 2024, of which 3,436 of these RSUs vested on July 2, 2026. The sale reported on this\nForm 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.92 - $40.03 per share, inclusive. The Reporting Person undertakes to provide\nto the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nrange set forth in this footnote to this Form 4."}],"balance_after":208198,"source":{"system":"sec-edgar","filing":"0001764013-26-000081","document":"wk-form4_1783714376.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401326000081/wk-form4_1783714376.xml","form_type":"4"}},{"id":711208,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":28789,"kind":"person","name":"Stout Jay S","position":1,"cik":"0001702969","reported_name":"Stout Jay S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-07-10T20:12:58.000Z","date":"2026-07-08","kind":"sale","planned":false,"acquired":false,"shares":1399,"price":39.53,"value":55302.47,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"On April 2, 2024, the holder was granted 54,978 RSUs, as previously reported on a Form 4 filed on April 4, 2024, of which 3,436 of these RSUs vested on July 2, 2026. The sale reported on this\nForm 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.91 - $39.89 per share, inclusive. The Reporting Person undertakes to provide\nto the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nrange set forth in this footnote to this Form 4."}],"balance_after":208275,"source":{"system":"sec-edgar","filing":"0001764013-26-000081","document":"wk-form4_1783714376.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401326000081/wk-form4_1783714376.xml","form_type":"4"}},{"id":711207,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":28789,"kind":"person","name":"Stout Jay S","position":1,"cik":"0001702969","reported_name":"Stout Jay S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-07-10T20:12:58.000Z","date":"2026-07-08","kind":"sale","planned":false,"acquired":false,"shares":105,"price":39.99,"value":4198.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 1, 2025, the holder was granted 76,181 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on April 3, 2025, of which 4,761 of these RSUs vested on July 1, 2026.\nThe sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.92 - $40.03 per share, inclusive. The Reporting Person undertakes to provide\nto the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nrange set forth in this footnote to this Form 4."}],"balance_after":209674,"source":{"system":"sec-edgar","filing":"0001764013-26-000081","document":"wk-form4_1783714376.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401326000081/wk-form4_1783714376.xml","form_type":"4"}},{"id":711206,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":28789,"kind":"person","name":"Stout Jay S","position":1,"cik":"0001702969","reported_name":"Stout Jay S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-07-10T20:12:58.000Z","date":"2026-07-08","kind":"sale","planned":false,"acquired":false,"shares":1906,"price":39.53,"value":75344.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 1, 2025, the holder was granted 76,181 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on April 3, 2025, of which 4,761 of these RSUs vested on July 1, 2026.\nThe sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.91 - $39.89 per share, inclusive. The Reporting Person undertakes to provide\nto the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nrange set forth in this footnote to this Form 4."}],"balance_after":209779,"source":{"system":"sec-edgar","filing":"0001764013-26-000081","document":"wk-form4_1783714376.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401326000081/wk-form4_1783714376.xml","form_type":"4"}},{"id":725547,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":28789,"kind":"person","name":"Stout Jay S","position":1,"cik":"0001702969","reported_name":"Stout Jay S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-06-26T23:45:54.000Z","date":"2026-06-26","kind":"sale","planned":false,"acquired":false,"shares":6723,"price":38.94,"value":261793.62,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.76 - $39.13 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":211685,"source":{"system":"sec-edgar","filing":"0001764013-26-000074","document":"wk-form4_1782517552.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401326000074/wk-form4_1782517552.xml","form_type":"4"}},{"id":725546,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":28789,"kind":"person","name":"Stout Jay S","position":1,"cik":"0001702969","reported_name":"Stout Jay S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-06-26T23:45:54.000Z","date":"2026-06-26","kind":"sale","planned":false,"acquired":false,"shares":33277,"price":38.18,"value":1270515.86,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.74 - $38.56 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":218408,"source":{"system":"sec-edgar","filing":"0001764013-26-000074","document":"wk-form4_1782517552.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401326000074/wk-form4_1782517552.xml","form_type":"4"}},{"id":800999,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":28789,"kind":"person","name":"Stout Jay S","position":1,"cik":"0001702969","reported_name":"Stout Jay S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-04-24T20:05:56.000Z","date":"2026-04-23","kind":"sale","planned":false,"acquired":false,"shares":2754,"price":29.62,"value":81573.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 17, 2023, the holder was granted 100,000 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on April 19, 2023, of which 6,250 of these RSUs vested on April 17,\n2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is\nmandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.23 - $30.00 per share, inclusive. The Reporting Person undertakes to provide\nto the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nrange set forth in this footnote to this Form 4."}],"balance_after":251685,"source":{"system":"sec-edgar","filing":"0001764013-26-000055","document":"wk-form4_1777061153.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401326000055/wk-form4_1777061153.xml","form_type":"4"}},{"id":810466,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":28789,"kind":"person","name":"Stout Jay S","position":1,"cik":"0001702969","reported_name":"Stout Jay S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-04-10T20:02:36.000Z","date":"2026-04-08","kind":"sale","planned":false,"acquired":false,"shares":1518,"price":24.83,"value":37691.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On April 2, 2024, the holder was granted 54,978 RSUs, as previously reported on a Form 4 filed on April 4, 2024, of which 3,436 of these RSUs vested on April 2, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.54 - $25.39 per share, inclusive. The Reporting Person undertakes to provide\nto the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nrange set forth in this footnote to this Form 4."}],"balance_after":254439,"source":{"system":"sec-edgar","filing":"0001702969-26-000006","document":"wk-form4_1775851354.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000170296926000006/wk-form4_1775851354.xml","form_type":"4"}},{"id":810465,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":28789,"kind":"person","name":"Stout Jay S","position":1,"cik":"0001702969","reported_name":"Stout Jay S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-04-10T20:02:36.000Z","date":"2026-04-08","kind":"sale","planned":false,"acquired":false,"shares":8614,"price":24.83,"value":213885.62,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 1, 2025, the holder was granted 76,181 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on April 3, 2025, of which 19,045 of these RSUs vested on\nApril 1, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The\nsale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the\nReporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.54 - $25.39 per share, inclusive. The Reporting Person undertakes to provide\nto the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nrange set forth in this footnote to this Form 4."}],"balance_after":255957,"source":{"system":"sec-edgar","filing":"0001702969-26-000006","document":"wk-form4_1775851354.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000170296926000006/wk-form4_1775851354.xml","form_type":"4"}},{"id":811516,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":28789,"kind":"person","name":"Stout Jay S","position":1,"cik":"0001702969","reported_name":"Stout Jay S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-04-09T20:19:05.000Z","date":"2026-04-07","kind":"grant","planned":false,"acquired":true,"shares":96851,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted pursuant to the Plan. The shares underlying the options will vest as to 25% of the total shares on April 1, 2027 and the balance will vest in thirty-six (36) successive substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date."}],"balance_after":96851,"derivative":{"exercise_price":24.61,"expiration_date":"2036-04-07","underlying":"Common Stock","underlying_shares":96851},"source":{"system":"sec-edgar","filing":"0001764013-26-000038","document":"wk-form4_1775765943.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401326000038/wk-form4_1775765943.xml","form_type":"4"}},{"id":811515,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":28789,"kind":"person","name":"Stout Jay S","position":1,"cik":"0001702969","reported_name":"Stout Jay S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-04-09T20:19:05.000Z","date":"2026-04-07","kind":"grant","planned":false,"acquired":true,"shares":66937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units (\"RSUs\") were granted pursuant to the Issuer's 2019 Equity Incentive Plan (the \"Plan\"). Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest as to 25% of the total shares on April 1, 2027 and the balance will vest in twelve (12) successive substantially equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date."}],"balance_after":264571,"source":{"system":"sec-edgar","filing":"0001764013-26-000038","document":"wk-form4_1775765943.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401326000038/wk-form4_1775765943.xml","form_type":"4"}},{"id":932396,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":28789,"kind":"person","name":"Stout Jay S","position":1,"cik":"0001702969","reported_name":"Stout Jay S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-01-23T21:21:29.000Z","date":"2026-01-21","kind":"sale","planned":false,"acquired":false,"shares":1977,"price":26.03,"value":51461.31,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 17, 2023, the holder was granted 100,000 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on April 19, 2023, of which 6,250 of these RSUs vested on January 17,\n2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is\nmandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":197634,"source":{"system":"sec-edgar","filing":"0001702969-26-000002","document":"wk-form4_1769203286.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000170296926000002/wk-form4_1769203286.xml","form_type":"4"}},{"id":942214,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":28789,"kind":"person","name":"Stout Jay S","position":1,"cik":"0001702969","reported_name":"Stout Jay S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-01-09T21:03:09.000Z","date":"2026-01-07","kind":"sale","planned":false,"acquired":false,"shares":55,"price":26.92,"value":1480.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 2, 2024, the holder was granted 54,978 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on April 4, 2024, of which 3,436 of these RSUs vested on January 2, 2026.\nThe sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.91 - $26.94 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":199611,"source":{"system":"sec-edgar","filing":"0001764013-26-000002","document":"wk-form4_1767992586.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401326000002/wk-form4_1767992586.xml","form_type":"4"}},{"id":942213,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":28789,"kind":"person","name":"Stout Jay S","position":1,"cik":"0001702969","reported_name":"Stout Jay S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-01-09T21:03:09.000Z","date":"2026-01-07","kind":"sale","planned":false,"acquired":false,"shares":1148,"price":26.51,"value":30433.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 2, 2024, the holder was granted 54,978 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on April 4, 2024, of which 3,436 of these RSUs vested on January 2, 2026.\nThe sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.90 - $26.89 per share, inclusive. The Reporting Person undertakes to provide\nto the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nrange set forth in this footnote to this Form 4."}],"balance_after":199666,"source":{"system":"sec-edgar","filing":"0001764013-26-000002","document":"wk-form4_1767992586.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401326000002/wk-form4_1767992586.xml","form_type":"4"}},{"id":1013837,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":28789,"kind":"person","name":"Stout Jay S","position":1,"cik":"0001702969","reported_name":"Stout Jay S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-10-24T20:36:56.000Z","date":"2025-10-22","kind":"sale","planned":false,"acquired":false,"shares":2520,"price":19.03,"value":47955.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 17, 2023, the holder was granted 100,000 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on April 19, 2023, of which 6,250 of these RSUs vested on October 17, 2025. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.03 - $19.23 per share, inclusive. The Reporting Person undertakes to provide\nto the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nrange set forth in this footnote to this Form 4."}],"balance_after":200814,"source":{"system":"sec-edgar","filing":"0001764013-25-000143","document":"wk-form4_1761338213.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401325000143/wk-form4_1761338213.xml","form_type":"4"}},{"id":1020328,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":28789,"kind":"person","name":"Stout Jay S","position":1,"cik":"0001702969","reported_name":"Stout Jay S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-10-10T20:01:57.000Z","date":"2025-10-08","kind":"sale","planned":false,"acquired":false,"shares":1585,"price":16.3,"value":25835.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 2, 2024, the holder was granted 54,978 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on April 4, 2024, of which 3,436 of these RSUs vested on October 2, 2025. The\nsale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the\nIssuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.06 - $16.48 per share, inclusive. The Reporting Person undertakes to provide\nto the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nrange set forth in this footnote to this Form 4."}],"balance_after":203334,"source":{"system":"sec-edgar","filing":"0001764013-25-000138","document":"wk-form4_1760126514.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401325000138/wk-form4_1760126514.xml","form_type":"4"}},{"id":1081420,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":28789,"kind":"person","name":"Stout Jay S","position":1,"cik":"0001702969","reported_name":"Stout Jay S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-07-25T21:11:45.000Z","date":"2025-07-23","kind":"sale","planned":false,"acquired":false,"shares":2805,"price":18.15,"value":50910.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 17, 2023, the holder was granted 100,000 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on April 19, 2023, of which 6,250 of these RSUs vested on July 17,\n2025. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is\nmandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":204919,"source":{"system":"sec-edgar","filing":"0001764013-25-000115","document":"wk-form4_1753477896.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401325000115/wk-form4_1753477896.xml","form_type":"4"}},{"id":1088620,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":28789,"kind":"person","name":"Stout Jay S","position":1,"cik":"0001702969","reported_name":"Stout Jay S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-07-11T20:13:45.000Z","date":"2025-07-09","kind":"sale","planned":false,"acquired":false,"shares":1519,"price":17.24,"value":26187.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 2, 2024, the holder was granted 54,978 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on April 4, 2024, of which 3,436 of these RSUs vested on July 2, 2025.\nThe sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.00 - $17.50 per share, inclusive. The Reporting Person undertakes to provide\nto the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nrange set forth in this footnote to this Form 4."}],"balance_after":207724,"source":{"system":"sec-edgar","filing":"0001764013-25-000108","document":"wk-form4_1752264819.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401325000108/wk-form4_1752264819.xml","form_type":"4"}},{"id":1165700,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":28789,"kind":"person","name":"Stout Jay S","position":1,"cik":"0001702969","reported_name":"Stout Jay S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-04-25T20:17:18.000Z","date":"2025-04-23","kind":"sale","planned":false,"acquired":false,"shares":1925,"price":14.79,"value":28470.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 17, 2023, the holder was granted 100,000 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on April 19, 2023, of which 6,250 of these RSUs vested on April 17,\n2025. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is\nmandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":209243,"source":{"system":"sec-edgar","filing":"0001764013-25-000083","document":"wk-form4_1745612230.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401325000083/wk-form4_1745612230.xml","form_type":"4"}},{"id":1173328,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":28789,"kind":"person","name":"Stout Jay S","position":1,"cik":"0001702969","reported_name":"Stout Jay S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-04-11T20:08:28.000Z","date":"2025-04-09","kind":"sale","planned":false,"acquired":false,"shares":5004,"price":12.99,"value":65001.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 2, 2024, the holder was granted 54,978 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on April 4, 2024, of which 13,744 of these RSUs vested on April 2, 2025. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.75 - $13.26 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":211168,"source":{"system":"sec-edgar","filing":"0001764013-25-000069","document":"wk-form4_1744402102.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401325000069/wk-form4_1744402102.xml","form_type":"4"}},{"id":1179765,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":28789,"kind":"person","name":"Stout Jay S","position":1,"cik":"0001702969","reported_name":"Stout Jay S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-04-03T20:51:53.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":107297,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the options will vest as to 25% of the shares on April 1, 2026 and the remainder will vest in 36 substantially equal monthly installments over three years thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date."}],"balance_after":107297,"derivative":{"exercise_price":15.2,"expiration_date":"2035-04-01","underlying":"Common Stock","underlying_shares":107297},"source":{"system":"sec-edgar","filing":"0001764013-25-000055","document":"wk-form4_1743713507.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401325000055/wk-form4_1743713507.xml","form_type":"4"}},{"id":1179764,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":28789,"kind":"person","name":"Stout Jay S","position":1,"cik":"0001702969","reported_name":"Stout Jay S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-04-03T20:51:53.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":76181,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units (\"RSUs\") were granted pursuant to the Issuer's 2019 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest as to 25% of the units on April 1, 2026, and the remainder will vest in substantially equal installments on a quarterly basis over three years thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date."}],"balance_after":216172,"source":{"system":"sec-edgar","filing":"0001764013-25-000055","document":"wk-form4_1743713507.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401325000055/wk-form4_1743713507.xml","form_type":"4"}},{"id":1295644,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":28789,"kind":"person","name":"Stout Jay S","position":1,"cik":"0001702969","reported_name":"Stout Jay S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-01-24T21:23:17.000Z","date":"2025-01-22","kind":"sale","planned":false,"acquired":false,"shares":2195,"price":23.59,"value":51780.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 17, 2023, the holder was granted 100,000 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on April 19, 2023, of which 6,250 of these RSUs vested on January 17,\n2025. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is\nmandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":139991,"source":{"system":"sec-edgar","filing":"0001764013-25-000019","document":"wk-form4_1737753791.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401325000019/wk-form4_1737753791.xml","form_type":"4"}},{"id":1381335,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":28789,"kind":"person","name":"Stout Jay S","position":1,"cik":"0001702969","reported_name":"Stout Jay S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2024-10-25T20:21:39.000Z","date":"2024-10-23","kind":"sale","planned":false,"acquired":false,"shares":2740,"price":29.53,"value":80912.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 17, 2023, the holder was granted 100,000 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on April 19, 2023, of which 6,250 of these RSUs vested on October 17, 2024. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.38 - $29.68 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":142186,"source":{"system":"sec-edgar","filing":"0001764013-24-000178","document":"wk-form4_1729887693.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401324000178/wk-form4_1729887693.xml","form_type":"4"}},{"id":1448101,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":28789,"kind":"person","name":"Stout Jay S","position":1,"cik":"0001702969","reported_name":"Stout Jay S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2024-07-26T20:20:52.000Z","date":"2024-07-24","kind":"sale","planned":false,"acquired":false,"shares":2813,"price":27.76,"value":78088.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 17, 2023, the holder was granted 100,000 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on April 19, 2023, of which 6,250 of these RSUs vested on July 17, 2024. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.37 - $28.06 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":144926,"source":{"system":"sec-edgar","filing":"0001764013-24-000143","document":"wk-form4_1722025247.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401324000143/wk-form4_1722025247.xml","form_type":"4"}},{"id":1534824,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":28789,"kind":"person","name":"Stout Jay S","position":1,"cik":"0001702969","reported_name":"Stout Jay S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2024-04-26T21:20:44.000Z","date":"2024-04-24","kind":"sale","planned":false,"acquired":false,"shares":7239,"price":28.9,"value":209207.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 17, 2023, the holder was granted 100,000 restricted stock units (\"RSUs\"), as previously reported on a Form 4 filed on April 19, 2023, of which 25,000 of these RSUs vested on April 17, 2024. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":147739,"source":{"system":"sec-edgar","filing":"0001764013-24-000087","document":"wk-form4_1714166431.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401324000087/wk-form4_1714166431.xml","form_type":"4"}},{"id":1547837,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":28789,"kind":"person","name":"Stout Jay S","position":1,"cik":"0001702969","reported_name":"Stout Jay S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-04-04T20:39:08.000Z","date":"2024-04-02","kind":"grant","planned":false,"acquired":true,"shares":68723,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the options will vest as to 25% of the shares on April 2, 2025 and the remainder will vest in 36 substantially equal monthly installments over three years thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date."}],"balance_after":68723,"derivative":{"exercise_price":30.78,"expiration_date":"2034-04-02","underlying":"Common Stock","underlying_shares":68723},"source":{"system":"sec-edgar","filing":"0001764013-24-000057","document":"wk-form4_1712263135.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401324000057/wk-form4_1712263135.xml","form_type":"4"}},{"id":1547836,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":28789,"kind":"person","name":"Stout Jay S","position":1,"cik":"0001702969","reported_name":"Stout Jay S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2024-04-04T20:39:08.000Z","date":"2024-04-02","kind":"grant","planned":false,"acquired":true,"shares":54978,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units (\"RSUs\") were granted pursuant to the Issuer's 2019 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest as to 25% of the units on April 2, 2025, and the remainder will vest in substantially equal installments on a quarterly basis over three years thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date."}],"balance_after":154978,"source":{"system":"sec-edgar","filing":"0001764013-24-000057","document":"wk-form4_1712263135.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401324000057/wk-form4_1712263135.xml","form_type":"4"}},{"id":1917272,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":28789,"kind":"person","name":"Stout Jay S","position":1,"cik":"0001702969","reported_name":"Stout Jay S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-04-19T20:23:19.000Z","date":"2023-04-17","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on April 17, 2024 and the remainder of the shares underlying the options vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date."}],"balance_after":150000,"derivative":{"exercise_price":15.47,"expiration_date":"2033-04-17","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001764013-23-000057","document":"wf-form4_168193578398335.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401323000057/wf-form4_168193578398335.xml","form_type":"4"}},{"id":1917271,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":28789,"kind":"person","name":"Stout Jay S","position":1,"cik":"0001702969","reported_name":"Stout Jay S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2023-04-19T20:23:19.000Z","date":"2023-04-17","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the number of shares underlying restricted stock units awards (\"RSUs\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"The RSUs vest over four years, with 25% of the RSUs vesting on April 17, 2024 and the remainder of the RSUs vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001764013-23-000057","document":"wf-form4_168193578398335.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401323000057/wf-form4_168193578398335.xml","form_type":"4"}},{"id":3957000,"issuer":{"id":114535,"kind":"organization","name":"Aravive, Inc.","symbol":"ARAV"},"owners":[{"id":28789,"kind":"person","name":"Stout Jay S","position":1,"cik":"0001702969","reported_name":"Stout Jay S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Common Stock","published_at":"2018-04-25T18:10:27.000Z","date":"2018-04-24","kind":"sale","acquired":false,"shares":4854,"price":1.55,"value":7523.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant."}],"balance_after":185646,"source":{"system":"sec-edgar","filing":"0001209191-18-026137","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513818/000120919118026137/doc4.xml","form_type":"4"}},{"id":4122214,"issuer":{"id":114535,"kind":"organization","name":"Aravive, Inc.","symbol":"ARAV"},"owners":[{"id":28789,"kind":"person","name":"Stout Jay S","position":1,"cik":"0001702969","reported_name":"Stout Jay S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Common Stock","published_at":"2017-12-22T17:09:09.000Z","date":"2017-12-20","kind":"grant","acquired":true,"shares":74500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of Restricted Stock Units that vest as follows:  25% of the shares vest on each of December 20, 2018, December 20, 2019, December 20, 2020 and December 20,2021."}],"balance_after":190500,"source":{"system":"sec-edgar","filing":"0001209191-17-067107","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513818/000120919117067107/doc4.xml","form_type":"4"}},{"id":4188744,"issuer":{"id":114535,"kind":"organization","name":"Aravive, Inc.","symbol":"ARAV"},"owners":[{"id":28789,"kind":"person","name":"Stout Jay S","position":1,"cik":"0001702969","reported_name":"Stout Jay S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Common Stock","published_at":"2017-10-10T20:17:10.000Z","date":"2017-10-06","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of Restricted Stock Units that vest as follows:  50% of the shares vest on each of October 6, 2018 and October 6, 2019."}],"balance_after":116000,"source":{"system":"sec-edgar","filing":"0001209191-17-056567","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513818/000120919117056567/doc4.xml","form_type":"4"}},{"id":4357679,"issuer":{"id":114535,"kind":"organization","name":"Aravive, Inc.","symbol":"ARAV"},"owners":[{"id":28789,"kind":"person","name":"Stout Jay S","position":1,"cik":"0001702969","reported_name":"Stout Jay S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-04-05T19:06:55.000Z","date":"2017-04-03","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option become exercisable on April 3, 2018 and 1/48 of the shares subject to the option become exercisable monthly thereafter"}],"balance_after":75000,"derivative":{"exercise_price":21.3,"expiration_date":"2027-04-02","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-17-025827","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1513818/000120919117025827/doc4.xml","form_type":"4"}},{"id":4357678,"issuer":{"id":114535,"kind":"organization","name":"Aravive, Inc.","symbol":"ARAV"},"owners":[{"id":28789,"kind":"person","name":"Stout Jay S","position":1,"cik":"0001702969","reported_name":"Stout Jay S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Common Stock","published_at":"2017-04-05T19:06:55.000Z","date":"2017-04-03","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of Restricted Stock Units that vest as follows: 25% of the shares subject to the Restricted Stock Units vest on each of April 3, 2018, April 3, 2019, April 3, 2020 and April 3, 2021."}],"balance_after":46000,"source":{"system":"sec-edgar","filing":"0001209191-17-025827","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513818/000120919117025827/doc4.xml","form_type":"4"}}]}